Study objective: To determine whether transient ischemic attack patients treated with an accelerated diagnostic protocol in an emergency department (ED) observation unit will experience shorter lengths of stay, lower costs, and comparable clinical outcomes relative to patients with traditional inpatient admission.
INTRODUCTION Background
An estimated 300,000 Americans are diagnosed with transient ischemic attack annually. 1 Transient ischemic attack is often the "smoke before the fire" because 10.5% of transient ischemic attack patients who present to the emergency department (ED) will have a stroke within 90 days. Of these strokes, half will occur within 2 days, 64% will be disabling, and 5% of patients will either die or experience a major adverse cardiac event. 2 Stroke remains a leading cause of death and disability, with estimated national costs of $57 billion in 2005. 1 Although there is consensus about the need for urgent evaluation and computed tomographic (CT) imaging of the brain, there is not consensus on the timing of other tests such as carotid imaging. Some recommend hospitalization of patients with new-onset transient ischemic attack if imaging studies cannot be performed urgently. However, the need for hospitalization of transient ischemic attack patients has been identified as an area of uncertainty. Treatment of transient ischemic attack patients in an ED observation unit has been suggested as an alternative. 3 Management in this setting often involves accelerated diagnostic protocols to expedite care. 5 However, it is not clear whether treatment of transient ischemic attack patients in this setting offers advantages or risks compared to traditional care, such as inpatient admission.
Goals of This Investigation
The objective of this study was to determine whether treatment of transient ischemic attack patients using an accelerated diagnostic protocol in the ED is associated with a decrease in the index visit length of stay and cost and with comparable diagnostic and 90-day clinical outcomes relative to traditional inpatient care.
MATERIALS AND METHODS

Study Design
This prospective randomized institutional review board-approved study was conducted at a university-affiliated 952-bed suburban teaching hospital. All patients were first evaluated in the ED and given the diagnosis of transient ischemic attack by a board certified emergency physician, without the aid of a neurologist. The initial ED evaluation included a medical history and physical examination; an ECG; cardiac monitoring; a CBC count with differential; tests for serum glucose, electrolyte, blood urea nitrogen, and creatinine levels; and a head CT. The ED has an adjacent ED observation unit where patients are treated by attending emergency physicians and physician assistants using condition-specific guidelines and protocols. 6, 7 The unit is staffed with roughly 1 nurse to 5 patients to facilitate efficient care.
Setting and Selection of Participants
Patients were screened and enrolled in the study 24 hours a day, 7 days a week, according to the patients' willingness to consent and the emergency physicians' availability to obtain consent. Patients were not considered for the study if they already had one of the outcomes for which testing was done, including a persistent neurologic deficit at consent, or if they had any existing conditions that prohibited reliable ED testing and outpatient follow-up. Patients were eligible for the study according to the absence of transient ischemic attack accelerated diagnostic protocol study exclusion criteria listed in Figure 1 . After the initial ED evaluation, when the decision to admit or observe the patient was made, informed consent was obtained by an emergency physician. Sealed envelopes with randomization assignments enclosed were prepared on a 1:1 ratio and were located in the ED and labeled with study numbers. To prevent physicians from determining randomization assignment by alternating study numbers, envelopes were assigned computer-generated random study numbers. After consent, randomization occurred by the attending emergency physician's opening the sealed envelope containing randomization assignment and admission order forms for either the accelerated diagnostic protocol (admission to the ED observation unit) or admission to an inpatient bed. Physicians, patients, investigators, and all providers were blinded to randomization assignment before the envelope was opened. According to randomization assignment, the emergency physician ordered the assigned admission and used the enclosed order forms for either accelerated diagnostic protocol or inpatient care.
Data Collection and Processing
Patients randomized to either accelerated diagnostic protocol or inpatient care had standardized written orders for the same 4 testing components: cardiac monitoring, carotid Doppler imaging, 2-dimensional echocardiography, serial nursing "neurochecks," and a neurology consultation. These tests were written on the order forms used for each respective unit. Patients assigned to either arm received appropriate antiplatelet therapy in the ED.
Patients admitted to the inpatient control group had their primary attending physician or hospitalist service attending physician contacted to discuss the patients' admission. From this discussion, the emergency physician completed the enclosed
Editor's Capsule Summary
What is already known on this topic Because patients with a transient ischemic attack are at risk for stroke and death, they often undergo an extensive evaluation designed to identify treatable causes.
What question this study addressed
Can protocol-based care delivered in an emergency department (ED) observation unit deliver the recommended testing safely and at a lower cost than traditional inpatient evaluation?
What this study adds to our knowledge In this randomized trial of 149 patients, those in the EDbased pathway typically completed testing more quickly and at a lower cost than those admitted to the hospital. As expected, death and subsequent stroke occurred infrequently in both groups.
How this might change clinical practice
Those choosing to implement an ED-based transient ischemic attack pathway may use this model, though the relative safety remains uncertain. inpatient admission order forms, and the patient was admitted to that attending physician, with most admissions being to the internal medicine service. The hospital has a designated stroke unit; however, a bed in that unit is not routinely available for transient ischemic attack patients. Alternatively, patients are admitted to an available regular medical floor and wear a portable cardiac monitoring device. The decision to cancel or modify the initial admitting orders and when to discharge the patient home was made by the admitting attending physician on a case-by-case basis.
The accelerated diagnostic protocol had been operational for more than 1 year before study initiation, and it was developed by a consensus group of physicians from emergency medicine, neurology, internal medicine, vascular surgery, and radiology. According to a literature review and group consensus, a protocol with 4 key diagnostic components was developed (Figure 1 ). Patients wore a cardiac monitor for at least 12 hours to detect paroxysmal atrial fibrillation or major dysrhythmias. Patients had serial neurologic checks every 2 hours for 12 hours and then every 4 hours, as well as consultation with a neurologist to help detect subtle strokes, crescendo transient ischemic attacks, or other clinically significant outcomes. Doppler carotid imaging was ordered to detect carotid stenosis more than 50%. Echocardiography was ordered to detect a possible cardioembolic cause of transient ischemic attack such as a patent foramen ovale, intramural thrombus, or major valvular disease. According to the neurology consultation, an additional transesophageal echocardiogram or nuclear magnetic resonance angiogram was performed if necessary.
Accelerated diagnostic protocol "disposition" was based on admission characteristics ( Figure 1 ) and could be made at any time throughout the day by the attending emergency physician. On completion of the protocol, accelerated diagnostic protocol patients were discharged home if they had no recurrent deficits, negative testing results, or negative serial clinical evaluation results and were clinically stable for discharge home with adequate home support. Discharge medications included appropriate antiplatelet therapy agreed on by the emergency physician with the neurologist and patient's primary physician. Accelerated diagnostic protocol patients who were discharged from the ED observation unit were instructed to follow up within 1 to 3 days with their primary care physician or neurologist.
Outcome Measures
The primary study outcome was index visit length of stay. Secondary outcomes were 90-day total direct cost and clinical outcomes, which include stroke, major clinical events, recidivism, the timeliness of diagnostic testing, the percentage of tests completed, and test outcomes. Index visit length of stay was measured using the time from arrival in the ED to discharge from the hospital. The ED length of stay was the time from ED arrival to admission to the hospital or ED observation unit. Accelerated diagnostic protocol results were detailed for the entire accelerated diagnostic protocol group and also subdivided 
Diagnostic Protocol
• Carotid imaging (Doppler, magnetic resonance angiography) to detect significant carotid stenosis requiring surgery. • Echocardiography to detect a possible cardioembolic source, including a patent foramen ovale, intramural thrombus, major valvular disease, or ventricular dyskinesis • Serial clinical evaluation to detect subsequent stroke, crescendo transient ischemic attacks, or other clinically significant outcomes. This includes serial assessments by nursing, emergency physicians, and physician assistants and a neurologist consultation.
• Cardiac monitoring for at least 12 h to detect paroxysmal atrial fibrillation requiring anticoagulation, or other major dysrhythmias
Admission Criteria
• Recurrent neurologic symptoms or development of a stroke • Significant carotid stenosis found on imaging, requiring urgent revascularization • Evidence of a thromboembolic source, requiring inpatient anticoagulation treatment with heparin • Unable to complete the evaluation or be safely discharged home in 18 to 24 hours, or if the physician thought that admission for other reasons was needed
• Known carotid stenosis (Ͼ50%) Figure 1 . The transient ischemic attack accelerated diagnostic protocol.
according to patients discharged or admitted from the ED observation unit. Ninety-day follow-up was completed on all patients by review of hospital records at the study hospital and a proximate affiliated hospital and by structured telephone interview by trained staff. Telephone interview covered subsequent stroke, related or major clinical events, and a modified Rankin score. The records of all hospital admissions or return visits to the ED within 90 days of the index visit were reviewed. Return visits were classified as related or unrelated return visits. A related return visit was defined as any return for symptoms or treatment related to the index visit transient ischemic attack, which included scheduled procedures such as endarterectomy or unscheduled related ED visits. Cases in question were reviewed by 3 investigators for consensus. Ninety-day clinical outcomes included index visit stroke, subsequent 90-day stroke, related major clinical events (seizures, patent foramen ovale closure, etc), and major adverse cardiac events (major dysrhythmia, new myocardial infarction, cardiac arrest, revascularization, new congestive heart failure, cardiac death).
Cost was measured using total direct hospital cost (only those costs directly related to providing patient care) for the index visit, which were further broken down into respective cost components (ie, radiology, laboratory, emergency). The costs of related return visits 90 days after the index visit discharge were subsequently added to the index visit cost to provide a composite 90-day cost for both groups. Total and direct facility costs were obtained from the hospital's cost accounting system, EPSi Activity Costing Module (Enterprise Performance Systems, Inc, St. Louis, MO). Costs are calculated in EPSi by "loading" the charge volume and expenses related to a hospital's provision of health care services, along with overhead expenses of running the hospital. Activity costs are then calculated by distributing the expenses down to each patient's individual charge code (or procedure) by relative value units as assigned by departmental managers or by a ratio of cost to charge, in which the assumption is that the use of resources is related to the dollar amount charged for the activity.
Patient charges were not studied, because charges are assigned differently by each hospital system, creating variability between institutions. The intent of this study was to understand the cost of care, not the charge variability that may exist between health care systems. Professional costs were also not studied, because these costs are separate from facility costs and are not uniformly available through our hospital cost accounting system. Because many of the primary care physicians and consultants involved in the patient's care are not hospital employees, it would not be possible to reliably collect their professional cost or charge information.
For overall comparison, data were also collected on all transient ischemic attack patients who were not enrolled in the study. These patients were identified from one of 2 sources: either an ED observation unit database or a hospital database of admitted patients. The hospital database was screened for patients with an ED visit code, an International Classification of Diseases, Ninth Revision (ICD-9) code for transient ischemic attack (4359), and a diagnosis-related group code for transient ischemic attack (diagnosis-related group 15 or 524). Using a flow diagram, nonstudy transient ischemic attack patient were compared with the study transient ischemic attack patients in terms of age, sex, index visit length of stay, and index visit total direct cost using EPSi.
Primary Data Analysis
Sample size calculations were based on the results of a feasibility analysis using 6 consecutive months of historical data from 2002. A comparison was made between 43 transient ischemic attack accelerated diagnostic protocol patients and 160 nonaccelerated diagnostic protocol inpatients (transient ischemic attack: DRG 15 and ICD-9 principal diagnosis 4359). In this analysis, 88% of accelerated diagnostic protocol patients were discharged with a length of stay of 15.7 hours and a total direct cost of $876 (admitted costs not included). By comparison, the nonaccelerated diagnostic protocol transient ischemic attack inpatients had an average length of stay of 3.8 days and total direct cost of $2,250. From this, we estimated that a sample size of 150 patients (75 per group) would allow 80% power to find an absolute reduction of length of stay of 1 day from 3.8 days in the standard group to 2.8 days in the accelerated diagnostic protocol group.
Descriptive statistics were generated by group about patient demographics (such as age and sex). Primary study outcomes were analyzed for distribution and found to not have a normal distribution. Using univariate statistical methods, we describe the median study outcomes of each group and provide interquartile ranges as a measure of spread. Differences in the medians of the length of stay and costs for each group were tested using Wilcoxon rank sums tests, and 95% confidence intervals of the difference between medians are estimated by the Hodges-Lehmann method, 8 which allows estimates of range between 2 nonnormally distributed medians. This estimate of difference was only done on primary outcomes for which the study was powered. All analyses were performed using SPSS, version 14.0 (SPSS, Inc., Chicago, IL).
RESULTS
During the study period, the average ED census was 116,244 visits per year. Between August 2003 and June 2005, 151 patients were enrolled in the study, with 2 patients excluded according to eligibility criteria, resulting in 75 patients randomized to the transient ischemic attack-accelerated diagnostic protocol group and 74 patients randomized to the inpatient control group (Figure 2 ) Study patients were similar between groups in terms of age, sex, stroke risk factors, and presenting symptoms (Table 1) . Eighty-five percent of patients randomized to the accelerated diagnostic protocol were discharged (Figure 2) . Patients randomized to the inpatient group spent slightly more time in the ED than study patients (6.6 versus 5.7 hours) because of inpatient admission processes.
Accelerated diagnostic protocol patient median length of stay (25.6 hours) was significantly less than inpatient length of stay (61.2 hours; PϽ.001) (Figure 2 ). The Hodges-Lehmann difference in median length of stays was 29.8 hours (interquartile range 41.6 to 22.5 hours) ( Table 2 ). Including data for the 2 excluded patients on an intention-to-treat basis provided the same lengths of stay for both study groups. Both study groups had a small cluster of patients whose length of stay Figure 3 . Histograms of length of stay (in hours) by study group. IPϭPatients were randomized to the inpatient course. Accelerated diagnostic protocol refers to patients randomized to the transient ischemic attack-accelerated diagnostic protocol course. Figure 4 . Histograms of ninety-day total direct cost by study group. IPϭPatients were randomized to the inpatient course. Accelerated diagnostic protocol refers to patients randomized to the transient ischemic attack-accelerated diagnostic protocol course. Obtained through the Hodges-Lehmann estimator of median differences and range (95% CI). Range estimates were applied only to primary outcomes for which the study was powered.
was greater than 120 hours. However, most accelerated diagnostic protocol patients' length of stay was 12 to 24 hours, whereas most of the inpatient control group had a length of stay of 48 to 84 hours (Figure 3) . The median length of stay of admitted accelerated diagnostic protocol patients was 100.5 hours, and that of discharged accelerated diagnostic protocol patients was 24.2 hours, with 18.4 hours in the ED observation unit (Figure 2) .
Median index visit total direct cost of accelerated diagnostic protocol patients was significantly less than that of the inpatient control group ($864 versus $1,528; PϽ.001) (Figure 4) . The Hodges-Lehman difference in median index visit cost was $617 (interquartile range $413 to $842) ( Table 2 ). The median 90-day total direct costs remained significantly less for accelerated diagnostic protocol patients as well ($890 versus $1,547; PϽ.001), with a Hodges-Lehman difference of $540 (interquartile range $312 to $810) ( Table 2 ). The sum total 90-day cost of all 75 accelerated diagnostic protocol patients was $66,851 less than that of the 74 inpatients. The median 90-day cost of accelerated diagnostic protocol patients who were discharged from the ED was $844, and the cost of admitted accelerated diagnostic protocol patients was $2,737. The individual 90-day cost components for the accelerated diagnostic protocol group was also lower in all categories, except for the ED visit, which was comparable. The difference in subgroup cost was greatest for room and board ($325), "all other" costs (including major procedures) ($256), and nonimaging diagnostic testing ($69).
When individual diagnostic test components were examined, carotid imaging was completed more frequently among accelerated diagnostic protocol patients (97% versus 91%) and in less time from arrival to the ED (median 13.0 versus 25.2 hours) ( Table 3 ). Both groups had 7 patients with greater than 50% carotid stenosis, but the inpatient group had 2 patients with greater than 70% carotid stenosis. Transthoracic echocardiography was also completed more frequently among All index-visit accelerated diagnostic protocol group strokes were identified while the patients were in the ED observation unit. The 7 accelerated diagnostic protocol stroke patients spent an average of 16.7 hours in the ED observation unit before inpatient admission. All strokes were small or ineligible for thrombolytic therapy. The remaining admitted accelerated diagnostic protocol patients were admitted for crescendo transient ischemic attacks (2), giant cell arteritis (1), and uncontrolled hypertension (1). All accelerated diagnostic protocol group admissions were for clinical events detected on serial clinical evaluations, with no admission primarily because of carotid stenosis, major arrhythmia, or echocardiographic findings.
Telephone follow-up and hospital record review were completed on all study patients (Table 4) . On 90-day follow-up, the 7 index-visit accelerated diagnostic protocol stroke patients had a median modified Rankin score of 1 (range 0 to 3). Three additional accelerated diagnostic protocol strokes occurred an average of 23 days after discharge. The 5 patients from the inpatient group who developed a stroke had a median 90-day modified Rankin score of 1 (range 0 to 4). For both groups combined, the incidence of stroke during the 90 days after discharge was 3.3%. During 90 days, both groups had 9 related return visits, representing 12% of each group. Other 90-day related major clinical events, including major adverse cardiac events, occurred in 4 patients in each group. During the study period, there were no deaths or adverse events attributable to the use of the accelerated diagnostic protocol.
LIMITATIONS
There are important limitations to consider in this study. Any study of consented patients is at risk of a convenience sampling bias according to patients who are willing to participate. However, comparison of patient demographics, length of stay, and index-visit total direct costs of both "study" and "nonstudy" transient ischemic attack patients shows that both groups are similar, suggesting that a sampling bias was not an issue (Figure 2) . We also did not consider professional costs. Admission of transient ischemic attack patients to a separate physician service involves the repeated work of a second "initial evaluation and management," with its associated costs and inpatient professional billing Current Procedural Terminology codes. However, when emergency physicians care for the same patient in an observation unit, it does not require this "rework," cost, or billing of a second set of professional Current Procedural Terminology codes, which suggests that if professional costs had been included, then they would have increased the cost of inpatient care relative to accelerated diagnostic protocol care. The study was not powered to show differences in the clinical outcomes of individual test categories or to show the accuracy of the accelerated diagnostic protocol. A larger study population would be needed to show this. This study also does not address what the impact of the accelerated diagnostic protocol might be on a health care system. A multicenter study would be best to demonstrate this. Because the results were from a single institution, they may need to be validated in other settings, such as hospitals with or without an ED observation unit or those with or without a dedicated stroke unit. Additionally, we cannot state that this protocol will perform the same in patients with small strokes. That would require a separate study.
DISCUSSION
In this study, we found that the length of stay and costs of transient ischemic attack patients managed using an accelerated diagnostic protocol were roughly half that of traditional inpatient admissions, with comparable clinical outcomes. The difference was largely due to patients who were discharged sooner because their accelerated diagnostic protocol testing result was negative. Additionally, more accelerated diagnostic protocol patients completed imaging tests during their index visit. Despite this additional testing, their costs remained lower. This result is similar to what has been described in studies of an accelerated diagnostic protocol for chest pain, with improved rates of diagnostic testing completion, such as stress testing, relative to an inpatient control group. 9, 10 The accelerated diagnostic protocol was successful in large part because of an institutional commitment of resources to provide prompt services to a selected group of patients, with the goal of early diagnosis or discharge. These resources include the timely performance and interpretation of imaging studies, an appropriately staffed ED observation unit, and timely consultative services, which were critical to the success of the accelerated diagnostic protocol and have been shown for other conditions, such as chest pain and syncope. 5, [9] [10] [11] It is estimated that 18% of EDs have an associated observation unit. 12 In addition, there are presently 319 hospitals that are accredited as a "Stroke Center" by the Joint Commission for the Accreditation of Hospital Organizations. 13 It seems reasonable that the accelerated diagnostic protocol cost benefits and efficiency would be reproducible in other hospitals that choose to commit resources to this protocol. As a rough estimate, if 18% of the 300,000 annual transient ischemic attack patients presented to US hospitals that offered an accelerated diagnostic protocol instead of admission, then the annual cost savings would be $29.1 million dollars. There are other potential cost benefits that we did not consider. In a costutility analysis by Nguyen-Huynh and Johnston, 14 hospitalizing transient ischemic attack patients for 24 hours to identify the few patients who would be eligible for thrombolytics was found to be of economic value, with a cost-effectiveness ratio of $55,044 per quality-adjusted life-year. This economic benefit would be in addition to those found in our study. Currently, the Centers for Medicare & Medicaid Services does not provide separate payment for the observation of patients with transient ischemic attack, citing the need for evidence of a distinct benefit. 15 The results of this study suggest that the Centers for Medicare & Medicaid Services should consider adding transient ischemic attack to its list of conditions covered by the ambulatory payment category for observation services. This is consistent with recommendations made by both the Medicare Ambulatory Payment Category Advisory Panel and the Institute of Medicine Report on the State of Emergency Medicine about better payment for emergency observation services. 16, 17 The savings realized in this study have significant national health care implications.
Of the diagnostic interventions in the accelerated diagnostic protocol, the "testing" component that most commonly led to inpatient admission was serial clinical examinations. All accelerated diagnostic protocol index visit strokes were found during the initial day of the patients' ED observation unit visit. This timing is similar to what Johnston et al 2 found, with most transient ischemic attack-related strokes occurring during the first 1 to 2 days after the transient ischemic attack. Our 11.4% incidence of stroke and 2.7% incidence of major adverse cardiac events during 90 days are also consistent with previous transient ischemic attack studies. 2, 18, 19 Because the accelerated diagnostic protocol involves accelerated diagnostic testing but no change in traditional therapies for transient ischemic attack patients, it is not surprising that clinical outcomes are similar to those of previous studies. However, using a standardized approach to transient ischemic attack patients may lend itself to introducing new therapies as they arise.
Although other diagnostic tests of the accelerated diagnostic protocol yielded few positive results, we believe that their role in the accelerated diagnostic protocol remains important. Carotid Doppler imaging plays an important role in risk-stratifying transient ischemic attack patients and identifying surgical candidates. Transient ischemic attack or stroke that is caused by "major artery" stenosis is associated with a stroke risk of 12.6% at 30 days and 19.2% at 3 months. In contrast, transient ischemic attacks or strokes caused by "small artery" stenosis are associated with a lower stroke risk of 2% at 30 days and 3.5% at 3 months. 20, 21 Patients with greater than 70% carotid stenosis show a 30.2% reduction in their 5-year risk of stroke and operative death if revascularization is performed within 2 weeks. That rate decreases to 17.6% if surgery is delayed to 2 to 4 weeks and 11.4% if it is delayed until 4 to 12 weeks. For transient ischemic attack patients with carotid stenosis, the timing of carotid testing and operative intervention is critical. Unfortunately, it has also been shown that transient ischemic attack patients experience many logistic barriers to the timely completion of office-based imaging and treatment. 22 Because of this and the potential for delays in outpatient surgical referrals, we chose to include carotid imaging in our protocol.
The need for immediate echocardiography and monitoring for atrial fibrillation to identify cardioembolic sources in transient ischemic attack is less clear. The risk of stroke in patients with a cardioembolic source is 4.6% at 1 month and 11.9% at 3 months, with a 61% reduction in the annual risk of stroke through the use of anticoagulation in patients with atrial fibrillation. 23 Because of these risks, we chose to include this additional testing. Perhaps the exclusion of higher-risk patients from the study selected a transient ischemic attack subgroup of sufficiently low risk of positive diagnostic testing, or the need for subsequent interventions, that they did not even need the accelerated diagnostic protocol. Potentially, they could be discharged directly from the ED. However, in examining our study group, using the Johnston et al 2 transient ischemic attack stroke risk score, 4 patients whose score was 2 had a stroke, and 5 patients whose score was 1 or less had either a major related neurologic event or a major adverse cardiac event. We suspect that the optimal solution may be a combination of risk stratification combined with an accelerated diagnostic protocol. These transient ischemic attack patient selection issues merit further study.
There has been much recent interest in implementing "brain attack" programs to rapidly initiate thrombolytic therapy in patients with acute ischemic strokes; however, less attention has been paid to programs to rapidly identify patients at higher short-term risk of stroke, such as transient ischemic attack patients. 13, 24 Although it is important to treat patients with ischemic stroke rapidly, much benefit may be realized if patients are identified and treated before brain tissue necrosis occurs. It has been suggested that the cerebral arteries of transient ischemic attack patients are actually at greater risk of subsequent neurologic deterioration than the arteries of patients who have had a stroke, which may be due to an unstable plaque that remains highly thrombogenic. 25 There are many similarities between the use of an accelerated diagnostic protocol for transient ischemic attack and accelerated diagnostic protocols for ED patients with chest pain. Chest pain accelerated diagnostic protocols have been more extensively studied, and there are currently 332 accredited chest pain centers in the United States. 26 Both transient ischemic attack and chest pain accelerated diagnostic protocols involve testing of a seemingly normal group of ED patients who may have a serious condition that is associated with significant morbidity, mortality, and liability. In both groups, the timeliness of testing is critical. In both, it is often not feasible to complete testing in a busy ED, yet discharge for outpatient testing may involve scheduling difficulties and risk to the patient. As with chest pain patients, roughly 85% of selected transient ischemic attack patients may be safely discharged after negative testing, in less time and at lower costs. 5 Previous studies have found that an accelerated diagnostic protocol for chest pain is associated with fewer admissions, greater inpatient bed availability, improved patient satisfaction, and fewer missed diagnoses. 27, 28 These are all outcomes to consider for future studies of an accelerated diagnostic protocol for transient ischemic attack. Learning from chest pain centers, organizations accrediting "stroke centers" might consider the inclusion of an accelerated diagnostic protocol for transient ischemic attack patients as an opportunity for expansion of the "stroke center" model.
There are many opportunities to further refine the accelerated diagnostic protocol according to newer technologies for transient ischemic attack patients. These include the use of multislice CT cerebral angiography, magnetic resonance imaging and magnetic resonance angiography, protein markers of transient ischemic attack, and transient ischemic attack riskstratification scores. 21 Additionally, future studies may determine whether patients with small strokes (National Institutes of Health stroke score Ͻ3) could be treated with a variation of the accelerated diagnostic protocol for transient ischemic attack patients.
In summary, the accelerated diagnostic protocol for transient ischemic attack patients that we have described is associated with an overall decrease in length of stay and costs, with clinical outcomes that are comparable to those of inpatient admission. In addition, this study suggests that shorter periods of observation, coupled with appropriate patient selection and active testing, may be adequate to identify transient ischemic attack patients who develop early adverse neurologic outcomes.
